JENKINTOWN, Pa., March 22, 2007 — The National Comprehensive Cancer Network (NCCN), an alliance of the world’s leading cancer centers, is pleased to introduce a new NCCN Member Institution—Vanderbilt-Ingram Cancer Center (VICC) in Nashville, Tennessee. With this addition, NCCN now includes 21 centers dedicated to improving the quality, effectiveness and efficiency of oncology practice so patients can live better lives.
Affiliated with Vanderbilt University and Medical Center, Vanderbilt-Ingram is committed to alleviating suffering from cancer through pioneering basic, translational and clinical research; compassionate care for patients, families and survivors; and cancer prevention, outreach and education. The center is led by its interim director, Jennifer Pietenpol, Ph.D., and an executive committee representing all areas of research, medical, surgical and radiation oncology; patient and community education and outreach; public affairs and communications; and other disciplines.
Vanderbilt-Ingram cares for nearly 4,000 new cancer patients each year. A National Cancer Institute-designated Comprehensive Cancer Center, Vanderbilt-Ingram is consistently ranked among the best places for cancer care by U.S. News & World Report and is among the top 10 nationally in competitively awarded NCI grant support.
“We welcome Vanderbilt-Ingram Cancer Center to the NCCN. Vanderbilt-Ingram is one of the nation’s leading cancer centers, with more than $150 million in annual research funding,” said William T. McGivney, Ph.D., Chief Executive Officer of NCCN. “Through their interdisciplinary collaborative methods, VICC is highly regarded as a leader in the development and delivery of high-quality cancer care.”
“Vanderbilt-Ingram is very pleased to join the NCCN,” said Jennifer Pietenpol, Ph.D., interim director at Vanderbilt-Ingram. “Promising discoveries in cancer research are being made every day, but our work is not finished until those findings are translated into advances in patient care. We are excited to join this group of cancer centers to help make that happen.”
Harold L. Moses, M.D., Vanderbilt-Ingram’s founding director and director emeritus, noted that joining NCCN had been a longtime goal of the cancer center. “I am very pleased that we have achieved this goal and we look forward to collaborating with our colleagues to improve cancer care for patients across the country.”